Skip to content

A study on minimum effective local anaesthetic dose (MLAD) of hyperbaric spinal ropivacaine for cesarean section

A study on minimum effective local anaesthetic dose (MLAD) of hyperbaric spinal ropivacaine for cesarean section

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000891
Enrollment
Unknown
Registered
2010-05-29
Start date
2009-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elective cesarean section

Interventions

bupivacine:spinal anesthesia with bupivacine
ropivacaine:spinal anesthesia with ropivacaine

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA physical status I or II, age 20-40 yr, body weight <85 kg, and height 150-170cm.

Exclusion criteria

Exclusion criteria: 1. Patients with known hypersensitivity to amide local anesthetics; 2. Patients with contraindications to spinal or epidural anesthesia, parturients who had obstetric complications or evidence of fetal compromise.

Design outcomes

Primary

MeasureTime frame
Sensory and motor block assessment;

Secondary

MeasureTime frame
vital signs;

Countries

China

Contacts

Public ContactZhiyu Geng
gengzhiyu_2005@yahoo.com.cn+86 010 83572632

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026